Annual CAPEX
$4.23 M
+$1.41 M+49.77%
December 31, 2023
Summary
- As of February 7, 2025, RNA annual capital expenditures is $4.23 million, with the most recent change of +$1.41 million (+49.77%) on December 31, 2023.
- During the last 3 years, RNA annual CAPEX has risen by +$3.14 million (+287.18%).
- RNA annual CAPEX is now at all-time high.
Performance
RNA CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CAPEX
$1.70 M
+$1.17 M+220.90%
September 1, 2024
Summary
- As of February 7, 2025, RNA quarterly capital expenditures is $1.70 million, with the most recent change of +$1.17 million (+220.90%) on September 1, 2024.
- Over the past year, RNA quarterly CAPEX has increased by +$781.00 thousand (+84.62%).
- RNA quarterly CAPEX is now -6.37% below its all-time high of $1.82 million, reached on March 31, 2023.
Performance
RNA Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CAPEX
$4.01 M
+$781.00 K+24.16%
September 1, 2024
Summary
- As of February 7, 2025, RNA TTM capital expenditures is $4.01 million, with the most recent change of +$781.00 thousand (+24.16%) on September 1, 2024.
- Over the past year, RNA TTM CAPEX has dropped by -$202.00 thousand (-4.79%).
- RNA TTM CAPEX is now -12.51% below its all-time high of $4.59 million, reached on June 30, 2022.
Performance
RNA TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
RNA CAPEX Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +49.8% | +84.6% | -4.8% |
3 y3 years | +287.2% | +113.0% | +76.8% |
5 y5 years | +8528.6% | +10000.0% | +1607.7% |
RNA CAPEX Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +49.8% | -6.4% | +1692.5% | -12.5% | +42.1% |
5 y | 5-year | at high | +1699.2% | -6.4% | +1692.5% | -12.5% | +3389.6% |
alltime | all time | at high | +8528.6% | -6.4% | +1692.5% | -12.5% | +3389.6% |
Avidity Biosciences CAPEX History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $1.70 M(+220.9%) | $4.01 M(+24.2%) |
Jun 2024 | - | $531.00 K(-42.0%) | $3.23 M(-2.7%) |
Mar 2024 | - | $915.00 K(+6.0%) | $3.32 M(-21.4%) |
Dec 2023 | $4.23 M(+49.8%) | $863.00 K(-6.5%) | $4.23 M(+0.3%) |
Sep 2023 | - | $923.00 K(+48.4%) | $4.21 M(+32.3%) |
Jun 2023 | - | $622.00 K(-65.8%) | $3.19 M(-18.0%) |
Mar 2023 | - | $1.82 M(+114.1%) | $3.88 M(+37.6%) |
Dec 2022 | $2.82 M(-24.5%) | $850.00 K(-894.4%) | $2.82 M(-23.3%) |
Sep 2022 | - | -$107.00 K(-108.1%) | $3.68 M(-19.8%) |
Jun 2022 | - | $1.32 M(+74.4%) | $4.59 M(+15.5%) |
Mar 2022 | - | $758.00 K(-55.6%) | $3.97 M(+6.2%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2021 | $3.74 M(+242.5%) | $1.71 M(+113.4%) | $3.74 M(+64.8%) |
Sep 2021 | - | $800.00 K(+13.0%) | $2.27 M(-1.9%) |
Jun 2021 | - | $708.00 K(+34.9%) | $2.31 M(+44.1%) |
Mar 2021 | - | $525.00 K(+121.5%) | $1.61 M(+47.2%) |
Dec 2020 | $1.09 M(+364.7%) | $237.00 K(-72.0%) | $1.09 M(+15.4%) |
Sep 2020 | - | $845.00 K(>+9900.0%) | $946.00 K(+722.6%) |
Jun 2020 | - | $0.00(-100.0%) | $115.00 K(-53.1%) |
Mar 2020 | - | $10.00 K(-89.0%) | $245.00 K(+4.3%) |
Dec 2019 | $235.00 K(+379.6%) | $91.00 K(+550.0%) | $235.00 K(+63.2%) |
Sep 2019 | - | $14.00 K(-89.2%) | $144.00 K(+10.8%) |
Jun 2019 | - | $130.00 K | $130.00 K |
Dec 2018 | $49.00 K | - | - |
FAQ
- What is Avidity Biosciences annual capital expenditures?
- What is the all time high annual CAPEX for Avidity Biosciences?
- What is Avidity Biosciences annual CAPEX year-on-year change?
- What is Avidity Biosciences quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Avidity Biosciences?
- What is Avidity Biosciences quarterly CAPEX year-on-year change?
- What is Avidity Biosciences TTM capital expenditures?
- What is the all time high TTM CAPEX for Avidity Biosciences?
- What is Avidity Biosciences TTM CAPEX year-on-year change?
What is Avidity Biosciences annual capital expenditures?
The current annual CAPEX of RNA is $4.23 M
What is the all time high annual CAPEX for Avidity Biosciences?
Avidity Biosciences all-time high annual capital expenditures is $4.23 M
What is Avidity Biosciences annual CAPEX year-on-year change?
Over the past year, RNA annual capital expenditures has changed by +$1.41 M (+49.77%)
What is Avidity Biosciences quarterly capital expenditures?
The current quarterly CAPEX of RNA is $1.70 M
What is the all time high quarterly CAPEX for Avidity Biosciences?
Avidity Biosciences all-time high quarterly capital expenditures is $1.82 M
What is Avidity Biosciences quarterly CAPEX year-on-year change?
Over the past year, RNA quarterly capital expenditures has changed by +$781.00 K (+84.62%)
What is Avidity Biosciences TTM capital expenditures?
The current TTM CAPEX of RNA is $4.01 M
What is the all time high TTM CAPEX for Avidity Biosciences?
Avidity Biosciences all-time high TTM capital expenditures is $4.59 M
What is Avidity Biosciences TTM CAPEX year-on-year change?
Over the past year, RNA TTM capital expenditures has changed by -$202.00 K (-4.79%)